UPC_APP_58035/2024

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Procedural & sub-applicationsCosts AssessmentsMilan LDGenericWritten Phase

Overview Decisions Citations Documents Timeline

Parties

Claimants

Insulet Corporation

Reps: Marc Grunwald

Respondents

A. Menarini Diagnostics s.r.l.

Reps: Martin Kohler

Judges

Pierluigi Perrotti
Alima Zana
Anna-Lena Klein
Uwe Schwengelbeck

Patents

EP4201327
EP 4 201 327

CPC codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291…

Sector: Packaging & Conveying

Outcome

Dismissed

Filed: Oct 24, 2024

First decided: Dec 30, 2024

Language: English

Milan Local Division dismissed Insulet Corporation's application for a cost decision following the rejection of EOFLOW Co. Ltd.'s intervention request in PI proceedings (EP 4 201 327). The court found the application inadmissible: a cost decision under R. 150 RoP requires a prior decision on costs in principle under R. 118.5 RoP. The order rejecting the intervention (1 October 2024) contained no such costs-in-principle decision, so the cost-determination application lacked the prerequisite under R. 156(e) RoP. Insulet was invited to resubmit once a costs award decision was obtained.

Open on UPC Registry